Aigen Investment Management, LP Tricida, Inc. Transaction History

Aigen Investment Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.37 - $9.46 $22,134 - $47,914	-5,065 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$8.56 - $26.93 $202,889 - $638,294	-23,702 Reduced 82.39%	5,065 $46,000
Q2 2020 Aug 10, 2020	BUY	$21.21 - $31.55 $583,168 - $867,467	27,495 Added 2161.56%	28,767 $791,000
Q1 2020 May 08, 2020	BUY	$18.43 - $38.04 $23,442 - $48,386	1,272 New	1,272 $28,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.